ALERTS Group’s Post

🗣"What does good support look like for you?" We are asking this question to clients as part of our follow-up process upon completing our survey. Here is what we have been told, which will be added to weekly ⤵️ Thank you for sharing. https://lnkd.in/eB8uqN-7 #gamblingharm #gamblingtreatment #gamblingsupport

🗣"What does good support look like for you?" We are asking this question to clients as part of our follow-up process upon completing our survey. Here is what we have been told, which will be added to weekly ⤵️ Thank you for sharing. https://lnkd.in/eB8uqN-7 #gamblingharm #gamblingtreatment #gamblingsupport

Reminder: Details of the reporting requirements are outlined in our MedPharma Transparency Newsletter.  To learn more, contact us at: compliance@vectorhealth.net #VectorHealthCompliance #MedPharmaTransparency #GlobalTransparencyReporting

In case you missed it! 💡 Rpharmy has created a handy ROI Case Study that calculates the real cost of manual hazardous drug management for hospitals and healthcare facilities. Based on interviews with customers, this resource helps you better understand and easily communicate the actual amount of time and staff required for tasks required for the HD communication plan in USP <800>. Click below to access 1., the Case Study and 2., our Safety First Blog that expands on how we created this insightful resource. https://loom.ly/u54M2D8 https://loom.ly/l5N4bbo #Rpharmy #HealthcareSoftware #ROICaseStudy #Rhazdrugs #Formweb #USP800

Have you completed CPE‘s #pharmacypressures survey? Complete it in just 10-15 mins before April 2nd here: https://lnkd.in/e_UhMtj5

Thoughts on this? >> NIH officials used personal emails, tweaked words to skirt FOIA searches during pandemic, lawmakers find >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #productmarketing #healthcare #biotech #pharmaceutical

Welcome to the ClinPGx Blog!

Exciting news for prevention professionals! The 2023 World Drug Report is now available, offering a deep dive into the latest trends in drug demand, supply, and the intricate dynamics of the global drug landscape. For the first time ever, the report introduces a dual format: an interactive online platform for user-friendly access to global, regional, and subregional data, paired with insightful booklets for comprehensive analysis. 🌍💡 This invaluable resource is tailored to empower our local drug prevention coalitions with the data and insights needed to refine strategies and make informed decisions. Let's leverage this knowledge to strengthen our community efforts and drive positive change! 🔗 Visit the United Nations Office on Drugs and Crime website today and start exploring the information. #drugdata #datavisualization #dataanalytics #dataanalysis #preventioncommunity #drugabusereport #substanceuseprevention #communitystrength #drugcoalitions

The integration of Artificial Intelligence (AI) into In-Vitro Diagnostic Medical Devices (IVD) promises transformative advances in patient care and diagnostics and is believed to bear the potential to revolutionize healthcare diagnostics. However, these innovations must navigate a complex web of regulatory challenges to ensure safety, efficacy, and compliance. Please attend our session "Artificial Intelligence in the context of the IVDR – How to keep the revolution under control" and gain valuable insights into the regulatory challenges and opportunities associated with AI in IVDs. #IVDR #artificialintelligence #compliance #changemanegement

At BioInformatiCo, we specialise in the implementation and management of safety databases, offering comprehensive safety reporting support throughout the trial duration. Our capabilities encompass early signal detection, safety reports and proactive management of clinical safety issues. Speak to us about your next clinical trial: info@bioinformatico.com Visit our website to learn more about us: https://lnkd.in/dq9z9F8k #bioinformatico #clinicaltrials #datamanagement #clinicaldatamanagement